TaiMed Biologics Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-167.78	-201.83	-194.81	-269.29	-470.93
Depreciation & Amortization	153.61	150.1	150.67	151.73	152.13
Other Amortization	-	4.18	4.72	4.72	4.53
Loss (Gain) From Sale of Assets	1.61	2.32	-	-	24.18
Asset Writedown & Restructuring Costs	80.89	-	-	-	-
Loss (Gain) From Sale of Investments	0.69	-	29.05	122.81	-26.76
Stock-Based Compensation	8.77	25.36	10.51	12.27	10.22
Other Operating Activities	-0.21	80.78	5.82	168.85	101.38
Change in Accounts Receivable	23.95	57.47	-62.24	59.54	97.94
Change in Inventory	89.44	185.47	110.85	-382.84	14.84
Change in Accounts Payable	80.25	-12.74	13.41	-122.49	116.79
Change in Unearned Revenue	-79.01	-113.31	-27.93	-339.16	113.91
Change in Other Net Operating Assets	-1.06	-557.36	-65.64	-11.33	-349.5
Operating Cash Flow	191.14	-379.55	-25.6	-605.21	-211.28
Capital Expenditures	-22.67	-8.06	-6.15	-3.56	-9.69
Sale of Property, Plant & Equipment	-	-	-	-	0.41
Sale (Purchase) of Intangibles	-0.1	-11.3	-	-1.21	-3.87
Investment in Securities	176.7	-695.39	-12.88	110.88	204.07
Other Investing Activities	0.09	-0.1	2.58	-	-
Investing Cash Flow	154.02	-714.84	-16.46	106.12	190.92
Short-Term Debt Issued	-	-	-	200	-
Total Debt Issued	-	-	-	200	-
Short-Term Debt Repaid	-	-200	-	-	-
Long-Term Debt Repaid	-29.5	-28.98	-16.05	-1.98	-1.93
Total Debt Repaid	-29.5	-228.98	-16.05	-1.98	-1.93
Net Debt Issued (Repaid)	-29.5	-228.98	-16.05	198.02	-1.93
Issuance of Common Stock	8.78	1,645	35.28	10.31	4.71
Other Financing Activities	-0.92	-4.27	-	0.05	0.01
Financing Cash Flow	-21.64	1,412	19.23	208.38	2.79
Foreign Exchange Rate Adjustments	-5.37	11.54	-0.28	13.21	-2.9
Net Cash Flow	318.15	329.22	-23.1	-277.51	-20.47
Free Cash Flow	168.48	-387.61	-31.75	-608.77	-220.96
Free Cash Flow Margin	27.56%	-63.52%	-6.46%	-108.13%	-53.44%
Free Cash Flow Per Share	0.61	-1.45	-0.13	-2.41	-0.88
Cash Interest Paid	10.74	12.71	14.76	9.88	7.44
Levered Free Cash Flow	315	-268.47	82.39	-217.42	-191.55
Unlevered Free Cash Flow	321.69	-260.59	91.65	-211.11	-186.9
Change in Working Capital	113.57	-440.47	-31.56	-796.29	-6.02

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.